Understanding the Motivation of Organ Donors in the Iranian Organ Market

How to cite

Sgroi, Daniel; Kelishomi, Ali Moghaddasi. 2017. "Understanding the Motivation of Organ Donors in the Iranian Organ Market." AEA RCT Registry. AEARCTR-0001709. https://doi.org/10.1257/rct.1709-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Daniel Sgroi* , Ali Moghaddasi Kelishomi

* Primary investigator

Registry ID
AEARCTR-0001709
DOI
https://doi.org/10.1257/rct.1709-1.0
First registered
Last updated
Status
In development
Trial dates
2017-07-24 – 2019-10-01
Countries
Private
JEL codes
I11, I12, D83, D84
Registry record
http://www.socialscienceregistry.org/trials/1709

Abstract

The Iranian organ market is unique: it matches those who have kidneys they are willing to donate with those who need them, but also allows for the sale of those kidneys. The NGO which administers the market and the medical procedures involved in the transplantation have granted us access to patients prior to their operations and repeated interaction with them in the months that follow. We would like to use this opportunity to investigate the motivations of patients (and should have access to those who decide to donate and those who do not): in particular, to test both the degree of habituation to both the health and financial ramifications of the procedure and the extent to which that habituation is correctly anticipated by patients over a period of several months (before and after the procedure). This will be combined with a tests designed to tease out plausible controls, confounds or corroborating factors (such as risk preference, patience levels, reported subjective well-being, personality traits, planning aptitude and cognitive ability) as well as demographic, personal and employment data on the individuals. We are also hoping to compare key characteristics of the group of donors with a control group of a similar socio-economic background.

Intervention

The key intervention will be decision to sell a kidney on the Iranian organ market. There are also a number of decisions subjects will make as part of the ongoing experiment.

Experimental design

A group of patients who plan to undergo kidney transplants will be followed over a number of months and surveyed/tested before and after the procedure.

Design details

Randomization method
The decision of who is to be put forward for the organ translant will be in the hands of the NGO and patients.
Randomization unit
Individuals are selected on medical grounds (kidneys are matched from donors to planned recipients).
Clusters
We are clustering down to the inidividual level.
Observations
The aim is to exceed 200 patients, with a similar sized control group (200 individuals). If we can do so we will try to go significantly above this number but we are subject to health considerations and donor-matching which may limit our numbers in practice and are outside of our control.
Arms
200 patients (organ donors), 200 control: we hope to go beyond this (possibly to something like 400 & 400) but there are medical/natural limits to how many patients we will be able to involve which are outside our control.
Primary outcomes
Key variables include personal and demographic variables, together with details of employment history, risk preferences, patience levels, whether patients opted to go through the procedure or not, personality traits, measures of planning aptitude and risk, performance in cognitive and behavioural tests and we will collect data on expectations and beliefs and see to what extent these expectations and beliefs are satisfied after the intervention, and again following some time from the intervention.

Cited by

No citation data available for this registration yet.

Keywords